Baseline staging of newly diagnosed prostate cancer: a summary of the literature.
about
Imaging of prostate carcinomaMagnetic resonance image in the diagnosis and evaluation of extra-prostatic extension and involvement of seminal vesicles of prostate cancer: a systematic review of literature and meta-analysisEvolution of urological imagingImaging on nodal staging of prostate cancer.The science and practice of bone health in oncology: managing bone loss and metastasis in patients with solid tumorsUpdated trends in imaging use in men diagnosed with prostate cancer.Tissue biomarkers for prostate cancer radiation therapy.Lymph node staging in prostatic carcinoma revisited.Analysis of Geometric Shifts and Proper Setup-Margin in Prostate Cancer Patients Treated With Pelvic Intensity-Modulated Radiotherapy Using Endorectal Ballooning and Daily Enema for Prostate ImmobilizationDiagnostic and therapeutic use of radioisotopes for bony disease in prostate cancer: current practice.Imaging in genitourinary cancer from the urologists' perspective.Management of prostate cancer patients with lymph node involvement: a rapidly evolving paradigm.Whole pelvic intensity-modulated radiotherapy for high-risk prostate cancer: a preliminary report.Prostate-specific Antigen as a Risk Factor for Skeletal Metastasis in Native Ethnic African Men with Prostate Cancer: A Case-control Study.Patterns of outcome and toxicity after salvage prostatectomy, salvage cryosurgery and salvage brachytherapy for prostate cancer recurrences after radiation therapy: a multi-center experience and literature review.Comparison of choline-PET/CT, MRI, SPECT, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a meta-analysis.Imaging and evaluation of patients with high-risk prostate cancer.Whole-body diffusion-weighted magnetic resonance imaging (WB-DW-MRI) vs choline-positron emission tomography-computed tomography (choline-PET/CT) for selecting treatments in recurrent prostate cancer.Detecting Tumor Metastases: The Road to Therapy Starts Here.The value of biomarkers in bone metastasis.Do all patients with newly diagnosed prostate cancer need staging radionuclide bone scan? A retrospective study.Comparison between conventional imaging (abdominal-pelvic computed tomography and bone scan) and [(18)F]choline positron emission tomography/computed tomography imaging for the initial staging of patients with intermediate- tohigh-risk prostate cancDiagnostic performance of 11C-choline PET/CT and bone scintigraphy in the detection of bone metastases in patients with prostate cancer.The role of biomarkers in the management of bone-homing malignancies.A Comparative Study of 68Gallium-Prostate Specific Membrane Antigen Positron Emission Tomography-Computed Tomography and Magnetic Resonance Imaging for Lymph Node Staging in High Risk Prostate Cancer Patients: An Initial Experience.When to perform positron emission tomography/computed tomography or radionuclide bone scan in patients with recently diagnosed prostate cancer.Prostate cancer screening: Canadian guidelines 2011Are staging investigations being overused in patients with low and intermediate risk prostate cancer?The role of 18F-fluoride PET-CT in the detection of bone metastases in patients with breast, lung and prostate carcinoma: a comparison with FDG PET/CT and 99mTc-MDP bone scan.[11C]Choline PET/CT detection of bone metastases in patients with PSA progression after primary treatment for prostate cancer: comparison with bone scintigraphy.Targeting and killing of prostate cancer cells using lentiviral constructs containing a sequence recognized by translation factor eIF4E and a prostate-specific promoter.Inappropriate utilization of radiographic imaging in men with newly diagnosed prostate cancer in the United States.(99m)Tc-HDP bone scintigraphy and (18)F-sodiumfluoride PET/CT in primary staging of patients with prostate cancer.Whole-body SPECT/CT for bone scintigraphy: diagnostic value and effect on patient management in oncological patients.See the unseen: Mesorectal lymph node metastases in prostate cancer.Usefulness of single photon emission computed tomography imaging in the detection of lumbar vertebral metastases from prostate cancer.Incidence of metastasis and prostate-specific antigen levels at diagnosis in Gleason 3+4 versus 4+3 prostate cancer.RETRACTED: Histopathology reports of findings of prostate needle biopsiesProstate-Specific Membrane Antigen PET Imaging in Prostate Cancer: Opportunities and ChallengesThe role of salvage brachytherapy for local relapse after external beam radiotherapy for prostate cancer
P2860
Q26865815-0B5DC3B5-67F1-4223-8274-E98B771876E9Q26998697-C6CEBB93-EAB9-4237-B218-CB532E8C9282Q27692114-96B33727-C1A9-439F-ACD5-0040F7ED8B48Q30244033-0AD2DE2E-95BD-440D-9F49-72535295528EQ34617864-F397FC17-BDCA-4DB8-8F3D-CDBC51C607F7Q34704662-2BE4C425-188B-42F0-9601-B195F95383A0Q36141341-12850E51-21C5-49D4-9E5A-DE9A6BF822ACQ36258503-F7DF364E-ABC8-4A6E-AEC2-36A947F9B44AQ36478072-036C73FA-CAA4-43AC-8100-DEAB6E6039E0Q36736397-79C8A6CD-AB2B-4665-B4A2-C54C268988C6Q36834536-4BD30DC0-6136-4AD5-ADB6-7FC4810CF83BQ37086178-048AB000-35A5-4925-9691-749B97860745Q37549491-742C6BD9-F9AE-4A93-B66F-C534FB51C7B7Q37649206-9920C237-F4B5-4809-A896-A1632FECC2B7Q38035794-DA13A937-F30D-4A05-A042-5155975F9130Q38212848-9155E8BC-490B-44D6-80DB-8AAE0A33F417Q38611187-41CC733E-E222-494D-A966-BA8994153821Q38802235-E7C5256C-491C-43F7-B399-FB502B895032Q38950545-45CD6240-8969-4A3C-B3B2-2B05A6D8D6FDQ39400189-B23260DA-047D-4780-B3F1-E07EF0861D7FQ39963882-3BFAEF19-ACAC-4291-BB95-BA37DE33C713Q41482900-87A7FB90-7712-4335-BF42-82D0B33775C4Q41563753-EF5647A5-E48F-4B8A-8121-846D1BE995F0Q41692580-1A6DB6AE-F73A-4C13-BAE9-2FF6B60FA17DQ41826244-C7E1B2F8-E356-4FB8-AB12-E09B2D2675D8Q42088489-D8749A09-60F9-4325-B4D1-83502EA57BA3Q42848548-22EDDED0-D5E7-40EF-B726-81745F236945Q43977098-54160D27-0452-4D73-823E-F8CCD0595E11Q44150197-FEF5657D-2535-4DD1-B3DD-314D06D34D6DQ45330298-B0E6D798-982B-4947-B683-E91773503E2DQ45885528-D5835170-2B2A-40CF-86D9-B741A9D05E58Q46617885-9512AC52-8EAD-40C9-B739-8AAB8A56CA7DQ46780712-F9B3F5F2-4A19-42A1-8691-D52CED78503CQ53097524-EC96A81F-71EB-4CA2-A52C-D4D37A825FDDQ53174206-DD5FE16A-CDB5-427E-88BD-BF905846410DQ53421961-8EA9494E-96FF-4735-8B22-BD0753B26E12Q53687040-0E9479DD-BDA2-40AF-9F00-D3E92BF109CBQ56533035-3E386F7B-EB68-4E42-AFF6-4DFEE086B80DQ57107208-24736E99-16BA-4564-9C4B-F75110FF3EA4Q57112397-1F3C28BF-08AD-49DA-BABE-97B184D2DE10
P2860
Baseline staging of newly diagnosed prostate cancer: a summary of the literature.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Baseline staging of newly diagnosed prostate cancer: a summary of the literature.
@ast
Baseline staging of newly diagnosed prostate cancer: a summary of the literature.
@en
type
label
Baseline staging of newly diagnosed prostate cancer: a summary of the literature.
@ast
Baseline staging of newly diagnosed prostate cancer: a summary of the literature.
@en
prefLabel
Baseline staging of newly diagnosed prostate cancer: a summary of the literature.
@ast
Baseline staging of newly diagnosed prostate cancer: a summary of the literature.
@en
P2093
P1476
Baseline staging of newly diagnosed prostate cancer: a summary of the literature.
@en
P2093
Himu Lukka
Sadeq Abuzallouf
P304
P356
10.1097/01.JU.0000123981.03084.06
P407
P433
P577
2004-06-01T00:00:00Z